Endoplasmic reticulum stress‑induced cell death as a potential mechanism for targeted therapy in glioblastoma

Pengfei Shi1, Zhuohang Zhang2, Jie Xu1

  • 1State Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing 400716, P.R. China.

Insights

Endoplasmic reticulum (ER) stress triggers apoptosis in glioblastoma (GBM) cells. Targeting ER stress may enhance GBM sensitivity to temozolomide, offering a novel therapeutic strategy.

Area of Science:

  • Cell Biology
  • Neuro-Oncology
  • Molecular Medicine

Background:

  • The endoplasmic reticulum (ER) is vital for protein homeostasis, lipid synthesis, and calcium storage.
  • ER stress occurs when unfolded or misfolded proteins accumulate, potentially leading to cell apoptosis via the unfolded protein response (UPR).
  • Glioblastoma (GBM) is an aggressive brain tumor with limited treatment options.

Purpose of the Study:

  • To review mechanisms of ER stress-induced apoptosis.
  • To identify factors influencing ER stress.
  • To evaluate ER stress as a potential therapeutic target for GBM.

Main Methods:

  • Literature review of ER stress, UPR, and glioblastoma.
  • Analysis of molecular pathways linking ER stress to apoptosis.
  • Evaluation of preclinical and clinical data on ER stress modulators in GBM.

Main Results:

  • ER stress can induce apoptosis in cancer cells, including GBM.
  • Factors like genetic mutations and microenvironment influence ER stress levels.
  • ER stress may sensitize GBM cells to chemotherapy, such as temozolomide.

Conclusions:

  • ER stress is a critical factor in GBM pathogenesis and treatment response.
  • Targeting ER stress pathways presents a promising therapeutic avenue for glioblastoma.
  • Further research is warranted to optimize ER stress-based therapies for GBM.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...